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Abstract
Intracellular pathogens including the apicomplexan and opportunistic parasite Toxoplasma gondii profoundly modify their
host cells in order to establish infection. We have shown previously that intracellular T. gondii inhibit up-regulation of
regulatory and effector functions in murine macrophages (MW) stimulated with interferon (IFN)-c, which is the cytokine
crucial for controlling the parasites’ replication. Using genome-wide transcriptome analysis we show herein that infection
with T. gondii leads to global unresponsiveness of murine macrophages to IFN-c. More than 61% and 89% of the transcripts,
which were induced or repressed by IFN-c in non-infected MW, respectively, were not altered after stimulation of T. gondii-
infected cells with IFN-c. These genes are involved in a variety of biological processes, which are mostly but not exclusively
related to immune responses. Analyses of the underlying mechanisms revealed that IFN-c-triggered nuclear translocation of
STAT1 still occurred in Toxoplasma-infected MW. However, STAT1 bound aberrantly to oligonucleotides containing the IFN-
c-responsive gamma-activated site (GAS) consensus sequence. Conversely, IFN-c did not induce formation of active GAS-
STAT1 complexes in nuclear extracts from infected MW. Mass spectrometry of protein complexes bound to GAS
oligonucleotides showed that T. gondii-infected MW are unable to recruit non-muscle actin to IFN-c-responsive DNA
sequences, which appeared to be independent of stimulation with IFN-c and of STAT1 binding. IFN-c-induced recruitment
of BRG-1 and acetylation of core histones at the IFN-c-regulated CIITA promoter IV, but not b-actin was diminished by
.90% in Toxoplasma-infected MW as compared to non-infected control cells. Remarkably, treatment with histone
deacetylase inhibitors restored the ability of infected macrophages to express the IFN-c regulated genes H2-A/E and CIITA.
Taken together, these results indicate that Toxoplasma-infected MW are unable to respond to IFN-c due to disturbed
chromatin remodelling, but can be rescued using histone deacetylase inhibitors.
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Introduction
Toxoplasma gondii is a protozoan parasite that is highly prevalent
in humans and warm-blooded animals throughout the world. As a
member of the Apicomplexa, it is obligatory intracellular and
actively invades a broad range of both immune and non-immune
cells within its host. When replicating in an uncontrolled manner,
Toxoplasma infection can lead to severe tissue damage and life-
threatening disease, as observed after transmission to fetuses in
utero or after reactivation of persistent infection in immunocom-
promized patients [1]. In contrast, when the parasite is effectively
controlled by a mature immune system, infection is mostly
asymptomatic or benign but leads to Toxoplasma persistence for
the hosts’ life. The remarkable ability of the parasite to establish
chronic infection in immunocompetent hosts may depend on
various immune evasion strategies, which are facilitated by
extensive modifications of host cells following infection [2].
Interferon (IFN)-c is the most important cytokine that controls
T. gondii replication in vitro and in vivo [3–8]. IFN-c is highly
pleiotropic and regulates more than 200 known genes, although
the actual number is probably much higher [9–10]. During
toxoplasmosis, IFN-c is readily secreted by CD4
+, CD8
+ T cells
and natural killer (NK) cells leading to increased serum levels in
both mice and humans [5–6,11–14]. However, we and others
have previously shown that intracellular Toxoplasma parasites
inhibit expression of several IFN-c-regulated genes including those
encoding the major histocompatibility complex (MHC) class II,
inducible nitric oxide synthase (iNOS), p47 GTPases and
monokine induced by gamma interferon (MIG) in macrophages
(MW) [15–20]. IFN-c-regulated gene expression is also impaired in
other cell types infected with Toxoplasma such as astrocytes and
microglia [21] as well as human fibroblasts [22]. However,
interference with MW function may be particularly relevant,
because these cells are critical for the course of infection. It has
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are more permissive for parasite replication in vitro than other
blood leukocytes [23]. Furthermore, mouse monocytes support
substantial Toxoplasma propagation in vivo, and together with
dendritic cells are important vehicles, which facilitate hematoge-
nous dissemination within the host [24–25]. MW also orchestrate
the immune response to T. gondii following infection. Inflammatory
monocytes migrate into parasitized tissue, and fulfil vital
antimicrobial functions that control infection at initial sites of
parasite inoculation [26–28]. MW may also be required for the
development of efficient Th1-type adaptive T cell responses to T.
gondii infection [6,29]. Recently, Lykens and colleagues established
that CD68
+ cells of the macrophage lineage and their responsive-
ness to IFN-c are indeed decisive for parasite control and host
mortality during toxoplasmosis [30].
IFN-c activates gene expression mainly via the JAK/STAT1
signalling pathway resulting in the translocation of active STAT1
homodimers into the nucleus [31]. These then bind to gamma-
activated sites (GAS) in the promoters of IFN-c-responsive genes.
We and others found no defects in IFN-c-induced nuclear import
of STAT1 in T. gondii-infected murine macrophages [19] or
human fibroblasts [22]. Despite this, cells were unable to up-
regulate IFN-c-induced gene expression [19].
Gene transcription requires extensive remodelling of the three-
dimensional structure of chromatin and the assembly of the
transcriptional machinery at respective promoters. Covalent
modifications of histones including acetylation, methylation, or
phosphorylation at distinct residues have been recognized as
critical factors for the control of gene expression [32]. They dictate
the accessibility of DNA, and function as docking sites for the
binding of proteins that are required for transcriptional activation
or repression. Acetylation of histones is commonly associated with
activation of transcription whereas their deacetylation correlates
with repression [32]. Histones are mainly acetylated by histone
acetyl transferases (HATs) the activity of which is counteracted by
histone deacetylases (HDACs) [32]. Chromatin remodelling
complexes constitute a second group of enzymes, which are
involved in chromatin regulation and disrupt histone-DNA
contacts in an ATP-dependent process [33]. The prototypic
BAF (Brahma-related gene (BRG)/Brahma (BRM)-associated
factor) complex (related to the yeast SWI-SNF complex) [33] is
crucial for the expression of immune-related genes in response to
external stimuli. It is also required for activation of the prototypic
IFN-c-responsive promoters of GBP2, CIITA and HLA-DR [34–
37]. BAF complexes often cooperate with histone-modifying
enzymes to regulate genes including those induced by IFN-c
[33–34,38].
Given the crucial roles of MW and their responsiveness to IFN-c
for the defence against T. gondii on the one hand [30], and the
parasite’s ability to inhibit the expression of distinct IFN-c-
regulated genes on the other hand [15,17,19–20], we sought to
determine the effect of Toxoplasma infection on IFN-c responsive-
ness of MW on a global scale. Using transcriptome analyses, we
show a general defect of infected murine MW to regulate gene
expression after activation with IFN-c. Subsequent mechanistic
analyses revealed an impairment of parasite-infected MW to
recruit components of chromatin remodelling complexes to
STAT1-regulated promoters and to acetylate histones in response
to IFN-c. Furthermore, we provide evidence that treatment with
HDAC inhibitors restores IFN-c responsiveness of Toxoplasma-
infected MW. We thus unravel key molecular mechanisms of this
intracellular protozoan parasite to facilitate survival in host MW,
which may be decisive for the successful establishment of infection.
Results
Unresponsiveness of Toxoplasma-infected macrophages
to IFN-c
In order to determine the global effect of T. gondii infection on
IFN-c responsiveness of macrophages, we performed whole
genome microarray analyses of murine bone marrow-derived
MW (BMMW), infected or not with T. gondii, and stimulated or not
with IFN-c (Figure 1A). Transcripts were obtained from four
biological replicates each. After reverse transcription and labelling,
cDNA was hybridized to microarray slides in a dye swap four
sample loop design (Figure 1B) providing a good average precision
and robustness [39]. Data were experimentally validated by real-
time PCR. Eighteen out of twenty primer pairs specific for
randomly selected genes from the microarray (Figure S1A)
amplified targets of the expected size. Comparison of mRNA
levels as obtained by microarray and quantitative RT-PCR
revealed a regression correlation of r=0.95, indicating a high
level of concordance between both methods (Figure S1B).
Out of 41,174 good quality microarray spots, 1,072 spots
representing 763 unique genes were at least 4-fold regulated
(absolute change) by IFN-c in non-infected BMMW at a false
discovery rate (FDR) of # 1% (Figure 1C; data is accessible
through NCBI GEO, accession number GSE28499). In contrast,
only 803 spots or 573 unique genes were regulated in T. gondii-
infected macrophages in response to IFN-c. This indicates that a
significant number of IFN-c-regulated genes could not be induced
or repressed by BMMW infected with Toxoplasma. We also
identified 815 genes that were at least 4-fold regulated in
untreated macrophages after parasite infection, as compared to
non-infected and untreated cells (Figure 1C). Remarkably, the
number of genes regulated by T. gondii further increased (1152
unique genes) in IFN-c-stimulated cells, indicating specific
parasite-macrophage interactions depending on the cytokine
milieu. Not surprisingly, the highest number of unique genes
Author Summary
Toxoplasma gondii is a common unicellular parasite of
humans and other vertebrates and can lead to overt
disease mostly in immune-suppressed patients or in
fetuses. Since IFN-c is the major mediator of resistance
against T. gondii, inhibition of IFN-c-mediated gene
expression may be a crucial mechanism to allow parasite
survival in the immune-competent hosts. Here, we used
genome-wide expression profiling to show that parasite
infection renders murine macrophages globally unrespon-
sive to stimulation with IFN-c. This results in severe defects
of infected macrophages to regulate a variety of immune-
related, but also immune-unrelated biological pathways.
By analysing the underlying mechanisms, we provide
substantial evidence that Toxoplasma interferes with the
assembly of chromatin remodelling complexes at IFN-c-
responsive DNA sequences. Furthermore, binding of the
transcription factor signal transducer and activator of
transcription 1 (STAT1) to IFN-c-regulated promoters, but
not its nuclear import is disturbed in infected cells. The
acetylation of histones at IFN-c-regulated promoters was
found to be severely impaired. Importantly, treatment with
histone deacetylase inhibitors rescues Toxoplasma-infect-
ed macrophages from the inability to respond to IFN-c.
Our study reveals new insights into the evasion of IFN-c-
mediated host immunity by T. gondii, and opens the
possibility of a novel intervention strategy against T. gondii
by modulating this parasite-host interaction.
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IFN-c-stimulated BMMW were compared with non-infected,
untreated control cells (Figure 1C).
A major goal of this study was to determine the effect of
Toxoplasma infection on IFN-c-triggered gene expression. There-
fore, we concentrated on genes which were regulated in response
to IFN-c, comparing non-infected with T. gondii infected cells.
After IFN-c stimulation, 567 and 505 genes were up- or down-
regulated (threshold level of $4-fold change), respectively, in non-
infected BMMW (Figure 2A; for a list of genes up- or down-
regulated in non-infected MW see Tables S1 and S2, respectively).
These numbers differ strongly from those found in human-derived
fibroblasts where the number of regulated genes was considerably
lower (n=127), and no genes were repressed by IFN-c [22].
Importantly, concomitant infection with T. gondii largely disabled
BMMW to respond to IFN-c (Figure 2A). Thus, the vast majority
of genes which were induced by IFN-c in non-infected BMMW
were not induced in Toxoplasma-infected cells (Figure 2A; Table
S1). Among them, several genes were identified that are known to
be repressed by T. gondii, including the MHC class II molecules
H2-Aa, H2-DMb1, H2-Ea [15–16], the interferon-regulatory
factor 1 (IRF-1) [16,22], the class II transactivator (CIITA)
[16,19], and the interferon gamma induced GTPase (IGTP)
[18]. However, we also identified several IFN-c-induced genes and
transcripts, the expression of which was even higher in Toxoplasma-
infected BMMW. These genes were up-regulated by Toxoplasma
infection itself as observed in either non-stimulated (ratio T. gondii,
untreated/n.i., untreated) or stimulated (ratio T. gondii, IFN-c/n.i.,
IFN-c) cells. This indicates that for distinct genes, parasite
infection can override the overall inhibitory effect of the parasite
on IFN-c-regulated gene expression (data not shown). Contrary to
IFN-c-induced transcripts, those repressed in non-infected mac-
rophages by IFN-c (IFN/Ctr # 0.25) were mostly increased after
infection (Figure 2A; Table S2). Quantitative analysis revealed that
genes, which were strongly induced or repressed by IFN-c were
also strongly inhibited or induced by T. gondii, respectively,
whereas genes that remained unchanged after IFN-c-treatment
were also mostly unaffected by the parasite (Figure 2B). Thus, the
level of IFN-c-induced regulation negatively correlated with the
change exerted by the parasite (correlation coefficient r=-0.62;
p,0.00001).
More than 60% of the genes (n=351) induced by IFN-c in non-
infected BMMW (based on a threshold level of $4-fold change)
were not induced in Toxoplasma-infected cells in response to IFN-c
(Figure 3A). Genes that were up-regulated in non-infected cells
mainly clustered into biological processes related to immunity, and
Toxoplasma infection decreased the number of genes within all
clusters considerably (Figure 3B). Furthermore, those IFN-c-
inducible genes that were repressed by T. gondii were significantly
enriched in processes involved in all aspects of the immune system,
but also other processes, e.g. lipid catabolism, signal transduction
and metabolic processes (Table S3A). On the other hand, 86%
(n=436) of the genes or transcripts that were repressed by IFN-c
in non-infected BMMW (IFN/Ctr # 0.25), were not regulated in
infected cells treated with IFN-c (Figure 3A). Furthermore, 3%
(n=14) of genes that were repressed in non-infected BMMW in
response to IFN-c were even up-regulated in cells infected with the
parasite (Figure 3A). Genes that were down-regulated after
stimulation of non-infected cells with IFN-c clustered into diverse
biological processes, including both immune-related and immune-
unrelated functions (Figure 3C). After concomitant infection with
T. gondii, most of the IFN-c-repressed processes appeared to be
heavily disturbed. In addition, genes which were down-regulated
by IFN-c in non-infected BMMW, but counteracted after parasite
infection were significantly enriched in several immune-related
processes, but also a large number of immune-unrelated processes
(Table S3B). This indicates that Toxoplasma not only targets IFN-c-
regulated immune mechanisms, but also other processes that are
Figure 1. Regulation of the transcriptome of primary murine macrophages after infection with T. gondii and/or activation with IFN-
c. (A) Primary BMMW were infected or not with T. gondii and 2 hours later, were stimulated with IFN-c for additional 22 hours or left untreated. RNA
from four biological replicates was used for further analysis. (B) After reverse transcription of mRNA and labelling with Cy3 or Cy5, two samples each
were hybridized to mouse whole genome microarrays in a dye-swap loop design as indicated by arrows. (C) Number of probes and corresponding
number of genes or transcripts that were at least 4-fold regulated at # 1% FDR.
doi:10.1371/journal.ppat.1002483.g001
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infection on the macrophage transcriptome was highly specific for
the response to IFN-c. Only 1.3% (n=518) of genes were up- or
down-regulated after parasitic infection which were not regulated
by IFN-c (Figure 3A). Taken together, these data show that
infection with T. gondii renders murine BMMW largely unrespon-
sive to stimulation with IFN-c, thereby preventing the activation of
various processes, which are mostly but not exclusively related to
host immunity.
Defective assembly of the chromatin remodelling
complex at GAS-containing sequences
We have shown previously that the IFN-c-induced trafficking of
STAT1 into the nucleus of Toxoplasma-infected murine macro-
phages or fibroblasts occurs as in non-infected controls [19] and
this was confirmed herein (see below) as well as by others using
human fibroblasts [22]. Since STAT1-induced transcriptional
activation was nevertheless inhibited by parasite infection [19], we
hypothesized a defect in chromatin remodelling and/or activation
of the basal transcriptional machinery.
To test this hypothesis, we first assayed nuclear extracts from
Toxoplasma-infected macrophages for their ability to bind GAS-
containing oligonucleotide probes. Activation with IFN-c for
30 minutes induced strong binding of nuclear components from
non-infected BMMW to a GAS consensus sequence (Figure 4).
Addition of an anti-STAT1a rabbit antibody, but not anti-STAT2,
anti-p48 or normal rabbit IgG supershifted the complex, thus
suggesting that the binding activity represented STAT1 homodi-
mers, i.e. the gamma-activated factor (GAF). However, when cells
had been previously infected with T. gondii, GAF formation was
strongly decreased as also reported previously [16]. Remarkably, we
identified a second GAS-binding complex with reduced electro-
mobility that specifically appeared in nuclear extracts from
Toxoplasma-infected BMMW, irrespective of whether cells were
activated with IFN-c or not (Figure 4). The parasite-induced
complexwasalsosupershiftedbyanti-STAT1,butnoneofthe other
antibodies tested. Together, these results suggested that a GAS-
binding complex of different composition than GAF is induced in
Toxoplasma-infected BMMW.
In an attempt to characterize differences in their protein
composition, GAS-binding complexes from Toxoplasma-infected
and non-infected macrophages were pulled-down, and were
separated by two-dimensional gel electrophoresis. Since initial
attempts failed to isolate sufficient material from nuclear extracts
of infected and non-infected cells for 2D gel electrophoresis and
subsequent mass spectrometry, we used complete cell extracts of
RAW264.7 monocytes/macrophages for these analyses. Following
silver staining of the 2D gels, several proteins were identified which
had been specifically pulled-down from non-infected, but not T.
gondii-infected MW after IFN-c treatment (Figure 5A). In contrast,
no proteins were detected, which were only present in GAS
oligonucleotide precipitates from parasite-infected MW treated
Figure 2. T. gondii infection severely impairs the ability of murine macrophages to respond to IFN-c. (A) The cDNAs from non-infected
and T. gondii-infected murine BMMW stimulated or not with IFN-c were hybridized to mouse whole genome microarrays. Microarray probes were
identified, which showed at least 4-fold up- or down-regulation in IFN-c-treated, non-infected cells versus untreated, non-infected cells. Expression
levels of the corresponding genes in non-infected (n.i.) and T. gondii-infected cells before and after IFN-c treatment are displayed following Z-score
transformation using a blue (induced) to yellow (repressed) scale. (B) Out of the 41,174 good quality spots, those which were differentially regulated
in at least one of the five comparisons as depicted in Figure 1B were selected (threshold 4-fold regulation; identified by ANOVA; n=3527). They were
subjected to a correlation analysis of the fold change of mRNA from non-infected control cells in response to IFN-c, and the impact exerted by T.
gondii on IFN-c-regulated gene expression. Vertical lines at 0.25 and 4 indicate lower and upper thresholds for differentially expressed genes. The
correlation coefficient r of the linear regression is indicated.
doi:10.1371/journal.ppat.1002483.g002
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c-treated, non-infected MW (indicated in Figure 5A by arrows) were
subsequently subjected to mass spectrometry. Mass finger print
analysesidentifiedtropomyosin3andputativebeta-actin(syn.actin,
cytoplasmic 1) or gamma-actin (syn. actin, cytoplasmic 2) as the hits
with the highest probability (Figure 5B). Importantly, non-muscle
actin is a constitutive component of chromatin remodelling
complexes, and is required for RNA polymerase II-driven
transcription [40–43]. Nuclear myosin 1 also plays important roles
in transcription by nuclear RNA polymerases [43], and tropomy-
osin has been recognized in nuclei of human cells [44], although its
nuclear function remains unknown. From the above results it was
thus tempting to speculate that infection with T. gondii inhibited the
assembly of chromatin remodelling complexes and/or the basal
transcription apparatus at GAS-containing promoters following
IFN-c treatment. To further corroborate this hypothesis, GAS
oligonucleotide pull-down assays were performed using extracts
from Toxoplasma-infected and non-infected RAW264.7 cells, before
and after treatment with IFN-c, and were analysed by immuno-
blotting. The results showed that STAT1 associated with GAS
sequences in an IFN-c-dependent manner, and that the amount of
precipitated STAT did not differ between infected and non-infected
cells (Figure 5C). This confirmed those data obtained by EMSA
showing that STAT1 protein complexes from Toxoplasma-infected
cells in principal do bind to GAS sequences, although mostly at
lower electromobility as compared to GAF (Figure 4), which was,
however, not retained under denaturing condition (Figure 5C).
Remarkably, b-actin recruitment to GAS oligonucleotides was
severely impaired after parasite infection, and this was similarly
observed whether cells were treated with IFN-c or not. This
Figure 3. Impact of Toxoplasma infection on the IFN-c-regulated transcriptome of murine BMMW as determined by mouse cDNA
microarray analyses. (A) Oligonucleotide probes on the array that were at least 4-fold up-regulated (IFN . Ctr) or 4-fold down-regulated (IFN ,
Ctr) after IFN-c treatment of non-infected BMMW, as compared to untreated controls were identified at a FDR # 1%, and were compared with un-
regulated probes (IFN = Ctr). Total numbers of probes are given at the top of each bar. The percentages of probes of which the up- or down-
regulation in non-infected cells was abrogated in Toxoplasma-infected cells (infected, IFN-c-treated vs. infected, untreated) are indicated by black and
cross-hatched bars, respectively. (B) Genes that were at least 4-fold up-regulated after IFN-c-treatment of non-infected (black bars) or Toxoplasma-
infected BMMW (cross-hatched bars) were clustered in biological processes using the DAVID Bioinformatics resource. Depicted are major IFN-c-
regulated clusters containing a minimum of 10 different genes, the expression of which was at least 4-fold induced after treating non-infected
macrophages with IFN-c. (C) Genes that were at least 4-fold down-regulated by IFN-c-treatment of non-infected (black bars) or Toxoplasma-infected
BMMW (cross-hatched bars) were clustered in biological processes using the DAVID Bioinformatics resource. Depicted are major IFN-c-regulated
clusters containing a minimum of 10 different genes, the expression of which was at least 4-fold repressed after treating non-infected macrophages
with IFN-c.
doi:10.1371/journal.ppat.1002483.g003
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independently of STAT1. BRG-1 is a core subunit of chromatin
remodelling complexes. It has nuclear ATPase activity and is
required for full activity of the complex [33]. In order to confirm a
defective recruitment of chromatin remodelling components in
lysates from Toxoplasma-infected MW, we also assayed GAS
oligonucleotide precipitates for complex formation with BRG-1.
The results showed its recruitment in non-infected macrophages in
an IFN-c-dependent manner, however, such binding was consid-
erably impaired in lysates from infected cells (Figure 5C). As
expected, immunoblotting of input lysates revealed no differences in
the abundance of total STAT1, b-actin or BRG-1 between infected
cells and non-infected controls, or between cells treated or not with
IFN-c (Figure 5C). Furthermore, the subcellular localization of b-
actin also remained unchanged following infection or IFN-c
treatment, as determined by immunoblotting of nuclear and
cytosolic extracts (Figure 5D) as well as by immunofluorescence
staining and confocal microscopy (data not shown). In contrast,
nuclear localization of STAT1 required previous activation of the
cells with IFN-c, and parasite infection did not interfere with this
STAT1 redistribution as described previously [19]. Controlstaining
of nuclear BRG-1 and cytosolic GAPDH confirmed the fraction-
ationofmacrophagesintonuclearandcytosolicextracts(Figure5D).
We next asked whether Toxoplasma infection also inhibits the
assembly of chromatin remodelling complexes at IFN-c-responsive
promoters in infected cells. To this end, the recruitment of BRG-1
as a core subunit of chromatin remodelling complexes to the IFN-
c-regulated CIITA promoter IV (CIITA pIV) was assessed by
chromatin immunoprecipitation (ChIP). Importantly, following
stimulation with IFN-c, BRG-1 increased 10-fold at the CIITA
pIV of non-infected cells, but was hardly detectable at CIITA pIV
of T. gondii-infected cells (Figure 5E; p,0.05, Student’s t-test). In
contrast, the abundance of BRG-1 did not significantly change at
ß-actin chromatin in infected or non-infected MW in response to
IFN-c. Together, these results suggested that T. gondii infection of
MW leads to an altered formation of STAT1-GAS complexes in
response to IFN-c, and to a defective assembly of chromatin
remodelling complexes at STAT1-responsive elements in vitro and
in vivo.
Defects of histone acetylation at IFN-c-responsive
promoters following infection
Actively transcribed genomic regions are characterized by post-
transcriptional modifications, including the acetylation of N-
terminal lysine residues of the core histones H4 and H3.
Acetylated histones facilitate euchromatin formation and assembly
of the transcriptional machinery on promoter DNA [32,45].
Hyperacetylation of histones H3 and H4 within the respective
promoter chromatin is also required for the IFN-c-induced up-
regulation of MHC class II or interferon-induced guanylate-
binding protein 2 (GBP2) [34,36]. Therefore, we next examined
the possibility of defective histone acetylation in Toxoplasma-
infected MW following IFN-c treatment using ChIP analysis. The
results showed an increase in the acetylation of histone H4 at the
CIITA pIV, following stimulation of non-infected MW with IFN-c,
however, such increase was not observed in Toxoplasma-infected
MW (Figure 6A). Neither control amplifications of CIITA pIV
using input DNA as a template, nor those of b-actin from anti-ac-
H4 ChIP precipitates revealed differences between infected and/
or IFN-c treated cells. Importantly, quantification by real-time
PCR indicated that infection with T. gondii abolished the IFN-c-
induced histone H4 acetylation of CIITA pIV chromatin by more
than 90% (Figure 6B; p=4 610
27; Student’s t-test). The extent of
inhibition of histone H4 acteylation concorded with the decrease
of IFN-c-regulated CIITA mRNA after parasitic infection, as
observed herein by microarray analyses (IFN-c-induced CIITA
mRNA: 32.04 in non-infected MW vs. 3.17 in Toxoplasma-infected
MW, see Table S1), or as previously shown by northern blotting
[16]. It is also in agreement with the inhibition of CIITA pIV
activity, as revealed by luciferase reporter assay [19]. In contrast to
CIITA pIV chromatin, no significant difference in the amount of
acetylated histone H4 was recognized between b-actin chromatin
from infected as compared to that from non-infected MW
(Figure 6B). Likewise, the IFN-c-induced acetylation of histone
H3 at CIITA pIV, but not at b-actin was significantly reduced
following infection with T. gondii (Figure 6C; p=0.006). Finally, the
acetylation of histones H3 and H4 in infected MW was also
impaired at the promoters of the IFN-c-regulated genes H2-Eb
and gbp2 (Figure 6D). It has to be stressed that the level of parasite-
imposed inhibition of histone acetylation differed between CIITA
pIV and H2-Eb on the one hand and GBP2 on the other
suggesting promoter-specific effects. Together, the data neverthe-
less clearly indicate severely impaired chromatin remodelling at
least at distinct IFN-c-responsive promoters in T. gondii-infected
macrophages.
HDAC inhibitors restore defective IFN-c responses in
Toxoplasma-infected MW
The activities of histone acetyl transferases (HATs) and histone
deacetylases (HDACs) govern the acetylation of histones, and are
crucial regulators of transcriptional activation and repression [32].
Aberrant histone modifications may result from an imbalance of
these modifying enzymes. HDAC inhibitors are being extensively
studied for their ability to counteract hypoacetylation of histones in
malignant cells, and they have been approved or are being
considered as epigenetic cancer therapies [46]. Since the defective
Figure 4. Binding activity of STAT1 homodimers to GAS-
containing DNA sequences is modulated after Toxoplasma
infection. Murine BMMW were infected or not with T. gondii for
24 hours, and were stimulated with IFN-c during the final 30 minutes,
or were left non-stimulated. Nuclear extracts were tested for their
binding to radiolabelled GAS-containing oligonucleotides by electro-
mobility shift assay. Supershift assays were performed using antibodies
against STAT1a, STAT2 or p48, or with normal rabbit IgG as a control.
GAF: gamma activated factor.
doi:10.1371/journal.ppat.1002483.g004
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inability to hyperacetylate histones H3 and H4 at IFN-c-
responsive promoters, we reasoned that HDAC inhibitors could
potentially restore IFN-c responses in infected cells. In order to test
this hypothesis, we determined H2-A/E expression in infected and
non-infected MW treated or not with the HDAC inhibitor MS-275
by fluorescence activated cell sorting (FACS). After treatment with
IFN-c, non-infected cells significantly up-regulated the expression
of H2-A/E molecules (p,0.01; Student’s t-test) on the cell surface,
however, concomitant infection with T. gondii diminished such
Figure 5. Toxoplasma infection leads to defective binding of components of chromatin-remodelling complexes to GAS-containing
oligonucleotides in vitro and to the IFN-c responsive CIITA promoter IV in infected cells. (A) RAW264.7 macrophages were infected with T.
gondii for 24 hours, or were left non-infected and stimulated with IFN-c during the final 30 min. Complete cellular lysates were used to isolate GAS-
binding protein complexes by a pull-down assay. Precipitates were resolved by isoelectric focussing and SDS-PAGE, and proteins were visualized by
silver staining. Protein spots that were specifically identified in the pull-downs from IFN-c-treated, non-infected MW are indicated. (B) GAS-binding
proteins that were pulled down from lysates of non-infected, but not Toxoplasma-infected MW after stimulation with IFN-c were analysed by mass
spectrometry. The three hits of highest probability for each of the four protein spots are shown; probability scores greater than 61 are considered
significant. (C) RAW264.7 macrophages infected or not with T. gondii for 24 hours were stimulated with IFN-c during the final 30 min, or were left
non-stimulated. Complete cellular extracts or proteins that had been pulled-down from the extracts, by using a biotin-conjugated GAS-containing
oligonucleotide and immobilized streptavidin, were subsequently analysed by immunoblotting using antibodies directed against STAT1, b-actin and
BRG-1. Nc: negative control: pull-down assay without lysate. (D) Nuclear and cytosolic extracts were prepared from RAW264.7 macrophages infected
with T. gondii, and stimulated with IFN-c as described in (C). After separation of the extracts by SDS-PAGE, STAT1, b-actin, GAPDH and BRG-1 were
detected by immunoblotting. (E) Toxoplasma-infected and non-infected (n.i.) RAW264.7 macrophages were stimulated with IFN-c for 2 hours, or were
left non-stimulated. After cross-linking DNA-protein complexes and shearing, chromatin was immunoprecipitated using an anti-BRG-1 antibody and
protein A agarose. After DNA isolation from immunoprecipitates or from input lysates, fragments of the CIITA promoter IV (pIV) or b-actin were
amplified by real-time PCR. The IFN-c-induced binding of BRG-1 was calculated according to the ratio (EChIP)
DCPChIP(unstimulated – IFN-c-treated)/
(Einput)
DCPinput(unstimulated – IFN-c-treated). Results are means 6 S.E.M. (n=2), significant differences were identified by Student’s t-test (*, p,0.05).
doi:10.1371/journal.ppat.1002483.g005
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expression in parasite-infected cells after stimulation with IFN-c
did indeed not differ significantly from that in non-stimulated
controls (Figure 7B; p=0.51). Infection with GFP-expressing
mutants of T. gondii showed that IFN-c-induced H2-A/E
expression was decreased in both parasite-positive and parasite-
negative cells of an infected MW population (Figure S2). This result
came unexpected since previous reports have suggested that IFN-
c-induced gene expression is predominantly inhibited in parasite-
positive cells of a Toxoplasma-infected host cell population [15,22].
It will be interesting to address this issue in the future and to re-
evaluate a possible involvement of a soluble factor either derived
from the parasite or the host cell. Both type II PTG and type I RH
parasites clearly diminished H2-A/E expression in response to
IFN-c although strain-specific differences in the levels of
suppression became apparent (Figure S2). Treatment of MW with
2 mM MS-275 prior to IFN-c stimulation potentiated H2-A/E up-
regulation in non-infected cells (Figure 7A, lower panel) as already
suggested by the findings of others [36]. Most importantly, MS-
275 also enabled Toxoplasma-infected MW to respond to IFN-c,a s
revealed by the significant up-regulation of H2-A/E molecules
following stimulation (Figure 7B; p,0.01). Infection with GFP-
expressing parasites revealed that MS-275 restored H2-A/E
expression in parasite-positive and parasite-negative cells of an
infected macrophage population (Figure S2). Furthermore, cells
harbouring type I RH or type II PTG parasites were rescued
following treatment with MS-275. Consequently, IFN-c-regulated
H2-A/E expression did not differ significantly between Toxoplasma-
infected and non-infected MW in the presence of MS-275
(Figure 7B; p=0.1). Control staining with an isotype-matched
control antibody did not reveal any significant fluorescence, and
did not differ between the various samples (Figure 7B). In addition,
prior control experiments showed that MS-275 at the concentra-
tions used in these experiments had no adverse effect on infectivity
or intracellular replication of T. gondii (Figure S3). Replication was
also observed in MS-275-treated macrophages in the presence of
IFN-c suggesting that these parasites employ additional mecha-
nisms to resist IFN-c-mediated cell autonomous immunity
different from those employed to interfere with IFN-c-induced
gene expression such as H2-A/E. These might be similar but not
identical to those recently described for type I parasites [47–48].
Together, these results clearly showed that MS-275 was able to
restore defective H2-A/E expression in Toxoplasma-infected MW.
RT-PCR analyses further corroborated the FACS data. The
transcript levels of H2-Ab strongly increased after activation of
non-infected MW with IFN-c, whereas prior infection with
Toxoplasma inhibited such increase 4.7-fold (Figure 7C). Impor-
tantly, the HDAC inhibitors MS-275 or sodium butyrate at 0.5 to
2 mM both diminished the Toxoplasma-imposed inhibition of H2-
Ab transcripts in a dose-dependent manner, and rescued infected
MW almost completely from their inability to up-regulate H2-Ab
at the highest concentration used. Similarly, the defective up-
regulation of CIITA as observed after infection of IFN-c-treated
MW with T. gondii was also dose-dependently diminished by
sodium butyrate and MS-275 (Figure 7C). Two mM sodium
butyrate did not diminish the intracellular replication of T. gondii as
already shown for MS-275 (Figure S3). Together, this suggests that
IFN-c-responsive promoters in general, including those directly
depending on STAT1 binding, can be rendered responsive, when
treating Toxoplasma-infected MW with HDAC inhibitors.
Mammals express a variety of different HDACs, which are
classified according to biochemical features and expression patterns.
They belong to one of four different classes, i.e. the classical HDAC
classes I, II and IV and the NAD
+-dependent sirtuins (also
designated class III HDACs) [49]. HDACs associate with different
co-regulators,andhavedifferentsubstratespecificities.Itwasthus of
further interest, whether we could identify specific HDACs that
are of particular relevance for Toxoplasma-imposed blockade of
Figure 6. Toxoplasma infection impairs IFN-c-induced acetylation of histones H3 and H4 at IFN-c-responsive promoters in murine
macrophages. (A) RAW264.7 macrophages were infected with T. gondii for 24 hours or were left non-infected, and were stimulated or not with IFN-
c during the final 16 hours. After cross-linking DNA-protein complexes, cell lysates were subjected to ChIP analysis using an anti-acetyl-H4 antibody
and protein A agarose. A no-antibody control was run in parallel (wo Ab). After isolation of DNA from chromatin immunoprecipitates or from input
cell lysates, fragments of the CIITA pIV or b-actin were amplified by real-time PCR. Amplicons were verified by agarose gel electrophoresis. Nc: PCR
negative control: without template. (B+C) Acetylation of histones H4 (B) and H3 (C) at the CIITA pIV and b-actin after stimulation of MW with IFN-c was
analysed by ChIP as described above andwas quantified according to the ratio (EChIP)
DCPChIP(unstimulated – IFN-c-treated)/(Einput)
DCPinput(unstimulated – IFN-c-treated).
Results are means 6 S.E.M. from three independent experiments, significant differences between the acetylation in non-infected (n.i.) and infected (T.
gondii)M W were identified by Student’s t-test (**, p,0.01). (D) The histone H3/H4 acetylation at the H2-Eb and the GBP2 promoters of non-infected and
Toxoplasma-infected MW was analysed by ChIP as described above (n=2).
doi:10.1371/journal.ppat.1002483.g006
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employed HDAC inhibitors with selective substrate specificities,
and measured their impact on IFN-c-induced H2-A/E expression.
The results showed that MS-275 (inhibits class I HDACs except
HDAC 8 [50]) and MC 1568 (inhibits class II HDACs [50])
increased the IFN-c-regulated H2-A/E expression of Toxoplasma-
infected macrophages considerably (Figure S4). Nicotinamide
(inhibits sirtuins [51]) increased H2-A/E expression of infected
cells only slightly, but it considerably decreased that of non-infected
cells, and therefore the net increase in infected and nicotinamide-
treated cells was considerable compared to infected and mock-
treated cells. Consequently, after treatment with the inhibitors
tested, H2-A/E expression of infected and non-infected MW did not
differ significantly as observed in mock-treated cells (Figure S4B).
Finally, MS-275, nicotinamide and MC1568 all diminished
Toxoplasma-mediated decrease in IFN-c-regulated H2-A/E expres-
sion to a similar extent (Figure 7D). As already shown for MS-275,
nicotinamide did not affect parasite replication whereas MC1568
diminished, but did not abolish parasite propagation (Figure S3).
We finally asked the question whether HDAC inhibition acts on
Toxoplasma-infected cells by increasing chromatin remodelling at
IFN-c-regulated promoters. To this end, histone H4 acetylation at
the CIITA pIV was analysed in MW treated or not with MS-275
by ChIP. The results showed that MS-275 increased IFN-c-
triggered acetylation of histone H4 in both non-infected and T.
gondii-infected cells, but the increase was clearly higher in infected
Figure 7. HDAC inhibitors restore responsiveness of Toxoplasma-infected macrophages to IFN-c. (A) RAW264.7 macrophages were
infected with T. gondii (parasite-host cell ratio 3:1), or were left non-infected and stimulated with IFN-c in the absence (upper panel) or presence of
2 mM of the HDAC inhibitor MS-275 (lower panel). Forty hours after infection, cells were immunolabelled with anti-H2-A/E and analysed by flow
cytometry. Results are from a representative experiment out of three, data are the percentages of cells within the individual quadrants. (B) Murine
macrophages were infected with T. gondii and/or treated with IFN-c and MS-275 as described in (A). Cells were immunolabelled with an antibody
directed against H2-A/E or an isotype-matched control antibody, and were analysed by flow cytometry (please consider the different scaling of the x-
axes in both plots). Data represent the mean percentages 6 S.E.M. of positive cells from three independent experiments. *: p,0.05, **: p,0.01, ns:
not significant (Student’s t-test). (C) IFN-c-induced transcript levels of CIITA and H2-Ab in infected and non-infected RAW264.7 macrophages after
treatment with HDAC inhibitors MS-275 or sodium butyrate. Cells were infected or not with T. gondii for 24 hours, and treated with IFN-c in the
absence (control) or in the presence of 0.5 or 2 mM sodium butyrate or 0.5, 1 or 2 mM MS-275 as indicated. After isolation of RNA and reverse
transcription of mRNA, CIITA, H2-Ab and b-actin were amplified, and semi-quantitatively analysed. IFN-c-induced CIITA and H2-Ab transcript levels in
T. gondii-infected and non-infected samples were normalized to b-actin, and the fold inhibition imposed by parasitic infection was calculated. Data
represent means 6 S.E.M. from three independent experiments. (D) Impact of HDAC inhibitors targeting different HDACs on Toxoplasma-mediated
inhibition of H2-A/E expression. Murine macrophages were infected with T. gondii and/or treated with IFN-c and MS-275, MC1568 (both at 2 mM) or
nicotinamide (5 mM) as described in (A). After immunolabelling with an antibody directed against H2-A/E, cells were analysed by FACS. The parasite-
imposed inhibition of IFN-c-induced H2-A/E expression was calculated; data represent means 6 S.E.M. from three independent experiments. (E)
Acetylation of histone H4 at the CIITA pIV in the presence or absence of MS-275. Toxoplasma-infected and non-infected MW (n.i.) were treated or not
with 2 mM MS-275, and stimulated with IFN-c or left non-stimulated. After cross-linking DNA-protein complexes, cell lysates were analysed by ChIP
using an anti-acetyl-H4 antibody. ChIP and input DNA were amplified by real-time PCR using primers specific for the CIITA pIV. The IFN-c-induced
H4 acetylation in the presence or absence of MS-275 was quantified according to the ratio (EChIP)
DCPChIP(unstimulated – IFN-c-treated)/
(Einput)
DCPinput(unstimulated – IFN-c-treated). Results are means 6 S.E.M. from two independent experiments.
doi:10.1371/journal.ppat.1002483.g007
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Thus, whereas there was a significant reduction in IFN-c-induced
H4 acetylation in T. gondii-infected cells as compared to non-
infected cells, this change was abolished in cells concomitantly
incubated with MS-275. Together, these results indicate that by
decreasing the activity of HDACs, and increasing histone
acetylation at IFN-c-responsive promoters, Toxoplasma-infected
murine MW can be rescued from the parasite-imposed unrespon-
siveness to IFN-c.
Discussion
Infections of mice or humans with T. gondii elicit a robust
inflammatory response with secretion of substantial levels of IFN-c
by CD4
+, CD8
+ T lymphocytes and NK cells [5–6,11–14]. IFN-c
production during toxoplasmosis is instrumental in orchestrating
and exerting cell-mediated immunity towards the parasite
[3,7,12,30], and it is therefore at first sight surprising, that even
high IFN-c responses do not suffice to eradicate T. gondii [13–14].
Using a genome-wide transcriptome analysis, we here show that
Toxoplasma renders murine MW largely unresponsive to stimulation
with IFN-c. We consider this a crucial mechanism of the parasite
to establish a productive infection in the immune-competent host.
Primary murine MW differentially regulated the expression of
763 unique genes in response to IFN-c, thus confirming the highly
pleiotropic activity of this cytokine [9–10]. Concomitant infection
with T. gondii, however, abrogated the expression pattern of the
majority of IFN-c-induced or IFN-c-repressed genes. It is
important to note, that interference of T. gondii with MW gene
expression is highly specific towards IFN-c-regulated genes.
Expression of only 1.3% of genes not regulated by IFN-c was
altered in parasite-infected cells as compared to non-infected
control cells. This rules out a general transcriptional defect of
Toxoplasma-infected MW, and thus confirms previous findings on
the repression of individual IFN-c-regulated genes by T. gondii
infection [15,18,20] on a genome-wide level. It also strongly
suggests that T. gondii specifically targets the JAK/STAT signalling
pathway, or the transcriptional activation in response to IFN-c.I n
addition to abrogating the expression of a large subset of IFN-c-
regulated genes, T. gondii considerably counteracted the expression
levels of the vast majority of the remaining IFN-c-regulated genes.
Consistent with the severe defect to respond to IFN-c, a wide
variety of biological processes was abolished in Toxoplasma-infected
MW as revealed by network analyses (see Table S3). These
included predominantly processes involved in regulatory and
effector functions of immunity, as it could be expected from the
main functions of IFN-c [9]. Remarkably, we also recognized
several biological processes being significantly affected by parasite
infection, which are at first sight not directly linked to the immune
system, e.g. skeletal system development, signal transduction,
membrane organization and lipid transport (see Table S3,
Figure 3). The impact of counteracting IFN-c-regulated gene
expression in MW on the host-pathogen interplay might thus be
broader than previously unravelled after analysing single immu-
nity-related genes [15–18,20]. However, the biological significance
of parasite interference with such processes still remains to be
determined. We also need to consider the critical anti-parasitic
activity of IFN-c during toxoplasmosis [3,7,12,30] as the main
driving force for T. gondii to evolve mechanisms for its efficient
inhibition.
It should be stressed that T. gondii parasites do not completely
abolish IFN-c-responses of murine MW. Several of those genes
induced or repressed by IFN-c in non-infected cells were still
differentially regulated by IFN-c in infected cells, although mostly
at a significantly reduced level. In contrast to human fibroblasts
[22], murine MW thus retain some residual responsiveness to IFN-
c after Toxoplasma infection. As discussed above this may relate to
the critical function of MW in immunity and their stronger
responsiveness to IFN-c compared to fibroblasts. We also
identified several genes, e.g. CXCL11, CFB, CD69, FLT1, CD14
or MMP9, the regulation of which was even amplified by T. gondii
infection (see Tables S1 and S2). Such synergism was in some cases
(e.g. CD69, IFIT2, MX1) attributed to additive effects on gene
regulation induced by Toxoplasma infection independently of IFN-
c. Mostly though, it required the concomitant presence of both
parasite and IFN-c. This indicates a complex differential impact of
T. gondii infection on MW gene expression that clearly differs
depending on the cytokine milieu. The molecular basis of the
differential regulation is not entirely clear, but may be due to the
additive or cooperative effect of IFN-c, and/or other factors due to
T. gondii infection. Importantly, residual IFN-c-responsiveness of
Toxoplasma-infected MW, and parasite regulation of IFN-c-
responsive genes may be critical to limit parasite replication at
least to some extent, and to favour host survival during acute
toxoplasmosis. This assumption is consistent with findings that
mice treated with IFN-c-depleting monoclonal antibodies, or with
a targeted disruption of the IFN-c or IFN-cR genes rapidly
succumb due to acute toxoplasmosis or reactivation of chronic
infection [3,7,12]. Similarly, the inability of immunocompromized
humans to control a chronic Toxoplasma infection may be
attributed to the loss of residual IFN-c-regulated gene expression,
when the T cell-mediated production of Th1-type cytokines
including IFN-c declines. Hence, we here propose that the large-
scale evasion of IFN-c responses by MW infected with T. gondii on
the one hand and the residual IFN-c regulated gene expression on
the other hand are crucial for establishment of a balanced parasite-
host interaction during toxoplasmosis.
Interference of T. gondii with IFN-c-mediated gene expression
on a global scale suggests a common underlying mechanism. This
was not self-evident since IFN-c not only activates the classical
JAK/STAT signalling pathway, but also the MEK-ERK
pathway, PI3K, G-protein linked C3G and Rap-1, Fyn kinase,
SHP-1 and -2 protein tyrosine phosphatases, as well as CRK
adaptor proteins [31,52]. Consequently, a remarkably large
number of genes are differentially regulated in STAT1
-/- BMMW
following IFN-c treatment [53]. Our study nevertheless revealed
a highly significant correlation between the levels of gene
regulation that were elicited by IFN-c and the parasite’s impact
on the IFN-c response. This further argues for a common
mechanism of T. gondii to counteract IFN-c-regulated gene
expression in MW. It should be stressed that we herein mainly
used a mouse-avirulent type II strain (NTE), i.e. a strain of the
clonal lineage, which is most commonly found in Europe and
North America. Whereas type I and type III strains of Toxoplasma
have been clearly shown to also inhibit IFN-c-regulated gene
expression of their host cells [20,22], we cannot currently rule out
additional mechanisms of these strains to inhibit the IFN-c
response of their host cells. Using mouse-virulent type I parasites,
Zimmermann et al. suggested the induction of SOCS-1, and
consequently a decrease in STAT1 tyrosine phosphorylation
within the host cell cytosol, leading to defective IFN-c-responses
of MW following infection [20]. Whereas this was not confirmed
in human fibroblasts, Kim and colleagues instead implicated a
dephosphorylation of nuclear STAT1 in particular following
infection with type I strain parasites [22]. These results
consistently indicate that mouse-virulent type I Toxoplasma strains
may have evolved additional means to inhibit IFN-c responses of
the host cell.
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Toxoplasma renders MW unresponsive to IFN-c via an impairment
of the chromatin remodelling at IFN-c-responsive promoters: (i)
recruitment of components of chromatin remodelling complexes
to GAS-containing oligonucleotides and to IFN-c-responsive
promoters was disturbed following infection, (ii) GAF formation,
i.e. binding of STAT1 homodimers to a GAS consensus sequence
was inhibited after infection, (iii) the IFN-c-induced acetylation of
core histones at different IFN-c-responsive promoters was strongly
decreased in infected cells, and (iv) treatment with HDAC
inhibitors rescued MW from the Toxoplasma-mediated inhibition
of IFN-c-induced gene expression (Figure 8). These results concur
with previous findings that despite normal translocation of STAT1
into the nuclei of infected cells following IFN-c treatment (see
[19,22] and Figure 5D, this study), transcriptional activation of a
luc reporter gene under control of IFN-c-responsive promoters was
nevertheless impaired [19]. The signalling event that we now
recognize to be altered in parasite-infected cells is an impaired
binding of actin and BRG-1 to GAS-containing oligonucleotides.
Importantly, recruitment of BRG-1, i.e. a core subunit of
chromatin remodelling complexes like BAF to the IFN-c-regulated
CIITA pIV was also inhibited in infected cells. Non-muscle actin is
another component of chromatin remodelling complexes, and
facilitates or even mediates their binding to chromatin [40]. It also
interacts with BRG-1, and is required for its full ATPase activity
[40]. During activation of the prototypic IFN-c-regulated
promoters of CIITA and GBP2, recruitment of BAF including
BRG-1 is required for subsequent binding of STAT1 and histone
acetylation [34,37]. EMSA indeed confirmed a diminished
formation of GAF, i.e. binding of STAT1 dimers to GAS in
Toxoplasma-infected MW as compared to non-infected controls.
Furthermore, acetylation of histones H3 and H4 in response to
IFN-c was also diminished in infected cells.
Intriguingly, the impaired binding of actin to GAS sequences
occurred independent of whether MW have been activated with
IFN-c and whether STAT1 or BRG-1 have bound to GAS. Actin
may thus also be constitutively present at IFN-c-responsive
promoters with reduced levels being observed in Toxoplasma-
infected cells. This result is remarkable, since it strongly supports
the hypothesis of an interference of the parasite with IFN-c-
regulated gene expression, which occurs independently of the
activity of STAT1. Kim et al. recently reported a partial decrease
of Tyr
701- phosphorylated STAT1 in the nuclei of human
fibroblasts, but they also stressed that this observation cannot
fully account for the inhibition of IFN-c-regulated gene expression
[22]. The impaired chromatin remodelling in Toxoplasma-infected
MW following stimulation with IFN-c as reported herein may
represent this hitherto unknown mechanism that accounts for
major parts of the inhibition of IFN-c-regulated gene expression
exerted by the parasite. The fact that defective IFN-c-mediated
gene expression of CIITA and MHC class II molecules in
Toxoplasma-infected MW can be largely abolished by treatment
with HDAC inhibitors also argues for impaired chromatin
remodelling rather than STAT1 activity as the major mechanism
to inhibit IFN-c responses in infected MW (see below). A parasite-
mediated defect in the recruitment of chromatin remodelling
complexes following activation of MW is appealing, since it might
also be responsible for impaired Ser
10 phosphorylation and Lys
9/14
acetylation of histone H3 at the TNFa and IL-10 promoters
following LPS or LPS/FccR stimulation, respectively [54–55].
Figure 8. Model of Toxoplasma-imposed inhibition of IFN-c-mediated gene expression, and the rescue of murine MW from such
unresponsiveness using HDAC inhibitors. In the absence of IFN-c, hypoacetylated histones due to predominant HDAC activity lead to compact
chromatin and repression of promoter activation (upper left). After stimulation with IFN-c, recruitment of BAF including the ATPase BRG-1 leads to
changes in chromatin structure that allows subsequent binding of STAT1 to its consensus sequence, recruitment of HATs, and hyperacetylation of
histones and non-histone proteins. Recruitment of BAF as well as full activity of BRG-1 and possibly other components of active STAT1-regulated
promoters require the presence of non-muscle actin. Finally, binding of IRF-1 allows binding of the transcriptional machinery and Pol II-driven gene
transcription (upper right). In Toxoplasma-infected MW, reduced levels of actin at STAT1-responsive promoters coincide with reduced recruitment of
chromatin remodelling complexes, including BRG-1 and HATs and thereby favour hypoacetylated chromatin. STAT1 does either aberrantly bind to
such promoters, or does not bind in infected cells (lower left). Treatment of Toxoplasma-infected MW with HDAC inhibitors leads to a shift towards
increased acetylation of histones and/or non-histone proteins, and thereby favours the switch to permissive chromatin following IFN-c activation.
This facilitates binding of transcription factors and chromatin remodellers in the presence of T. gondii, and allows binding of the transcriptional
machinery and IFN-c-induced gene expression (lower right).
doi:10.1371/journal.ppat.1002483.g008
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responses in Toxoplasma-infected MW can be restored using HDAC
inhibitors. This not only argues for chromatin modifications being
the primary target of T. gondii to counteract IFN-c responses in
MW (see above), but, more importantly, also opens up novel
possibilities for anti-parasitic treatment. A main function of
HDACs is to remove acetyl groups from histones, thereby
counteracting the activity of HATs and repressing gene expression
[49]. More recently, HDACs have been assigned additional
functions including the repression of CIITA activity [36], or the
co-activation of transcription of distinct genes including IFN-c-
dependent IP-10 [56]. Such requirement of HDAC activity may
be due to acetylation of non-histone proteins [57]. Importantly,
inhibitors of HDAC have been proven or are considered
promising chemotherapeutic agents for the treatment of several
human diseases including different malignancies and neurodegen-
erative diseases, and have already been approved for use in
humans or are in clinical trials [46]. Here we show that MS-275 or
sodium butyrate, i.e. widely used small molecule HDAC inhibitors
[50,58] rescue Toxoplasma-infected murine MW from the inhibition
of IFN-c-regulated gene expression. Importantly, treatment of
Toxoplasma-infected macrophages with MS-275 was accompanied
by a vigorous increase in acetylation of core histone H4 at the
IFN-c-responsive CIITA pIV. This therefore suggests that it
indeed acts by reversal of defective chromatin remodelling in
infected cells. HDAC inhibition thus suffices to induce a switch
from repressive towards permissive chromatin in Toxoplasma-
infected MW, and allows IFN-c-mediated gene expression
(Figure 8). We do not yet know the exact acetylation target(s)
which is crucial in rescuing the host cells. Recent analyses of the in
vivo acetylome have identified 3600 distinct lysine residues on 1750
proteins being acetylated in mammalian cells [59]. Beside histones
these include multiple proteins involved in chromatin remodelling,
cytoskeleton reorganisation, acetylation and methylation [59].
Therefore, we can currently not exclude the possibility, that either
in addition to or instead of histones, subunits of the chromatin
remodelling complex BAF show an acetylation defect in
Toxoplasma-infected cells, which is restored in the presence of
HDAC inhibitors. Screening of several inhibitors that target the
three major classes of HDACs, i.e. class I and class II HDACs as
well as sirtuins [50–51], revealed that a broad range of HDACs
mediate the parasite-imposed inhibition of IFN-c responsiveness.
This finding indeed argues for a scenario where inhibition of
HDACs results in a more general hyperacetylation of both
histones and chromatin remodellers that collectively allow
transcriptional activation of IFN-c-responsive genes despite of
the presence of T. gondii. It should also be stressed that distinct
HDAC inhibitors act on the parasite itself, and can exert potent
anti-Toxoplasma activity [60–61]. Control experiments excluded
that the HDAC inhibitors used in this study severely impair or
even kill the parasite (Figure S3). However, we cannot currently
completely rule out that HDAC inhibitors restore IFN-c
responsiveness of infected macrophages by more subtle alterations
to T. gondii’s physiology, e.g. by altering the expression of distinct
parasite effector molecules. The fact that HDAC inhibitors of
different chemistry and specificities consistently restored IFN-c
responses in infected macrophages, nevertheless clearly argues for
an effect on acetylation of host cell proteins rather than parasite
proteins.
Since parasite-imposed inhibition of IFN-c-induced expression
of H2-A/E molecules and CIITA were consistently abolished after
treatment with HDAC inhibitors, we currently assume that
inhibiting HDAC activity abrogates the global unresponsiveness
of Toxoplasma-infected MW to IFN-c. Due to the limited number of
genes investigated, we cannot, however, completely rule out that
expression of a subset of IFN-c-regulated genes remains
completely or partially inhibited after T. gondii infection, even in
the presence of HDAC inhibitors. Our finding nevertheless makes
the disturbed chromatin remodelling at IFN-c-regulated promot-
ers following Toxoplasma infection a promising and feasible target
for a supportive therapy of toxoplasmosis. Due to the critical
importance of IFN-c in the anti-parasitic immunity during
Toxoplasma infections [3,7,12,30], shifting the balance towards
more efficient IFN-c responses of MW and probably other host
cells may indeed facilitate parasite control, or may even suffice to
eradicate the infection. This would, to our knowledge, represent
the first time that a pathogens’ immune evasion strategy becomes a
target for an improved treatment of an infectious disease.
Materials and Methods
Macrophages, parasites and infection
Primary bone marrow-derived macrophages (BMMW) were
isolated from female BALB/c mice as described before [15].
Briefly, bone marrow cells were cultured in RPMI 1640
supplemented with 10% heat-inactivated FCS, 100 U/ml
penicillin, 100 mg/ml streptomycin and 20% L929-conditioned
medium as a source of M-CSF. After differentiation for 6 days,
adherent BMMW were incubated in RPMI 1640 medium (as
above) devoid of L929-derived supernatant. The murine leukae-
mia monocyte/macrophage cell line RAW264.7 (TIB 71; ATCC,
Rockville, MD) was cultured in RPMI 1640 containing 4.5 g/L
glucose, 10% FCS, 1 mM sodium pyruvate, 10 mM HEPES and
antibiotics. Tachyzoites of the mouse-avirulent type II strain NTE
[62] were propagated in L929 fibroblasts as described before [15].
Where indicated, GFP-expressing mutants of mouse-virulent type
I parasites (RH-LDM) or of mouse-avirulent type II parasites
(PTG/ME49) were used (kindly provided by Antonio Barragan,
Stockholm, Sweden). Prior to infection of macrophages, parasites
were isolated by differential centrifugation and thoroughly washed
[19]. Unless stated otherwise, cells were infected at parasite-host
cell ratios of 6:1 and 3:1 for 24 or 40 hours, respectively. Infected
macrophages or non-infected controls were stimulated with 100 or
300 U/ml recombinant mouse IFN-c (R&D Systems, Wiesbaden,
Germany) starting at 2 – 3 or 23.5 hours p.i. as indicated. In some
experiments, the following HDAC inhibitors were added at
2 hours prior to the stimulation with IFN-c: 0.5 or 2 mM sodium
butyrate, 2 mM MC1568, 5 mM nicotinamide (all from Sigma,
Steinheim, Germany), or 0.5 to 2 mM N-(2-aminophenyl)-4-[N-
(pyridine-3-ylmethoxycarbonyl)aminomethyl]benzamide (MS-275;
Merck, Darmstadt, Germany).
Microarray analysis
Twenty-four hours after infection, total RNA from Toxoplasma-
infected or non-infected primary BMMW that had been cultured
in the presence or absence of 100 U/ml IFN-c was isolated using
the RNeasy kit (Qiagen, Hilden, Germany). RNA quality was
assured using the Agilent 2100 Bioanalyser (Agilent Technologies,
Santa Clara, CA) before RNAs from 4 biological replicates each
were pooled, and then treated with DNase I. After phenol/
chloroform/isoamylalcohol extraction, isopropanol/sodium ace-
tate precipitation and RNA quality control as above, mRNA was
isolated using the Oligotex mini kit as recommended (Qiagen).
CyDye-labelled cDNA probes were prepared using the CyScribe
post-labelling kit, according to the manufacturer instructions
(Amersham Biosciences, Freiburg, Germany). Briefly, cDNA was
synthesized in the presence of amino allyl-dUTP using CyScript
reverse transcriptase and both random nonamer and oligo(dT)
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chemically labelled with Cy3 or Cy5 NHS-esters. Labelled cDNA
was purified using the GFX purification kit (Amersham Biosci-
ences). Finally, quantity and dye incorporation rates were assessed
using a NanoDrop ND-100. Per microarray, 0.3 mg Cy3 and Cy5-
labelled cDNAs, respectively, were simultaneously hybridized for
17 hours at 63uC to Agilent Technologies 44K mouse whole
genome 60-mer oligonucleotide microarrays representing
,41,000 mouse genes and transcripts. Slides were washed as
recommended (Agilent Technologies SSPE protocol), omitting
incubation in washing solution 3, and immediately scanned using
an Agilent G2505B microarray scanner.
The data presented herein were generated in compliance with
the MIAME guidelines, and have been deposited in NCBI’s Gene
Expression Omnibus. They are accessible through GEO Series
accession number GSE28499. Raw intensity data were normalized
with a non-linear Lowess regression [63]. Differentially expressed
genes were identified by an ANOVA fixed effects model [64].
Adjusted p-values were calculated by the Benjamini-Hochberg
method to control the false-discovery-rate [65]. The list of
regulated genes were functionally analysed by identifying common
annotation terms and subsequent clustering into biological
processes using the DAVID bioinformatics resources as described
before [66].
Subcellular fractionation of macrophages
Cytosolic and nuclear fractions of macrophages were prepared
as described before [67]. To this end, equal numbers of primary
BMMW or RAW264.7 monocytic cells that had been infected with
T. gondii for 24 hours, or left non-infected and/or stimulated with
300 U/ml IFN-c during the final 30 min were washed in PBS
containing 12.5 mM NaF and 1 mM Na3VO4, and collected by
centrifugation. After having been incubated for 15 min at 4uCi n
hypotonic lysis buffer (10 mM HEPES, pH 7.8, 10 mM KCl,
2 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 0.1 mM PMSF,
0.1 mM Na3VO4), cells were disrupted by adding 0.5% Nonidet
P-40, vigorous mixing and passage through a 26G needle.
Complete cell lysis was assured microscopically after trypan blue
staining. After centrifugation at 10,000 6g and 4uC for 1 min, the
supernatants containing cytosolic proteins were collected for
further analyses (see below). Nuclei were washed in hypotonic
lysis buffer (as above), before being extracted in 50 mM HEPES,
50 mM KCl, 300 mM NaCl, 1 mM DTT, 0.1 mM EDTA,
0.1 mM PMSF, 0.1 mM Na3PO4 and 10% glycerol for 20 min at
4uC. Soluble nuclear proteins were collected after centrifugation.
Electromobility shift assay (EMSA)
The STAT1-binding activity of nuclear extracts from Toxoplasma-
infected and non-infected BMMW was assayed against the GAS
sequence of the Fcc receptor I (FccRI) gene [68]. Briefly, after
annealing 1 mM each of the oligonucleotides (59-GTATTTCCCA-
GAA-39;5 9-CTTTTCTGGGAA-39), the DNA probe was radio-
labeled for 30 min with [
32P]dATP using Exo(-) Klenow enzyme as
recommended (Stratagene, La Jolla, CA, USA), isolated by
ammonium acetate/ethanol precipitation and washed. Equal
volumes of nuclear extract were then incubated for 45 min with
2 ml of radiolabeled DNA probe [50,000 cpm/ml], 1 mg poly(I)-
poly(C), 20 mM HEPES, 50 mM KCl, 4% Ficoll, and 1 mM each
DTT and EDTA. Supershift assays were performed by adding of
2 mg of rabbit anti-STAT1a (M-23), rabbit anti-STAT2 (L-20),
rabbit anti-p48 (C-20; all supershift grade antibodies from Santa
Cruz Biotechnology, Santa Cruz, CA) or normal rabbit IgG. The
protein-DNA complexes were resolved using a native 4%
polyacrylamide gel in 0.25x TBE and detected by autoradiography.
Pull down assay of GAS-binding protein complexes
The binding capacity of proteins from Toxoplasma-infected and
non-infected macrophages towards a GAS-containing DNA
oligonucleotide was compared using an in vitro pull-down assay.
RAW264.7 cells infected or not with T. gondii and stimulated with
300 U/mlIFN-c for30 minorleftnon-stimulatedwerelysed in1%
Triton X-100, 150 mM NaCl, 50 mM Tris/HCl pH 8.0, 50 mM
NaF, 5 mM sodium pyrophosphate, 1 mM PMSF, 1 mM EDTA,
1m MN a 3VO4 and 5 mg/ml each of leupeptin, aprotinin and
pepstatin. After centrifugation, soluble proteins were incubated for
2 hours at 4uC with 1 mM of a biotin-conjugated double-stranded
DNA probe containing the GAS sequence of FccRI (for: 59-biotin-
GATGTATTTCCCAGAAAAG-39; rev: 59-CTTTTCTGGGA-
AATACATC-39) [68]. Thereafter, DNA-protein complexes were
incubated for 60 min at 4uC with 30 ml of 50% slurry of UltraLink
immobilized streptavidin (Pierce, Rockford, IL, USA). After
washing twice in lysis buffer (see above) supplemented with
100 mM KCl and once in lysis buffer, DNA-protein complexes
were resolved by one- or two-dimensional PAGE.
Two-dimensional electrophoresis and mass spectrometry
Proteins isolated by GAS oligonucleotide pull-down assay were
desalted and concentrated using Centricon microseperators
(MWCO 3,000; Amicon, Beverly, MA). After lyophilization, they
were dissolved in 8 M urea, 2% CHAPS, 0.5% IPG buffer,
2.8 mg/ml DTT and bromphenolblue and separated in pH 3–10
Immobiline DryStrips using a IPGphor isoelectric focusing unit as
recommended (GE Healthcare, Freiburg, Germany). Immobiline
strips were then equilibrated for 15 min in 50 mM Tris/HCl,
pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 10 mg/ml DTT and
bromphenolblue, loaded on a 10% SDS-polyacrylamide gel and
covered with 0.5% agarose. Proteins were separated by standard
SDS-PAGE, and visualized by silver staining or colloidal
coomassie staining.
Following colloidal Coomassie Brilliant Blue G-250 staining,
proteins that had been differentially GAS-precipitated from
extracts of Toxoplasma-infected macrophages and non-infected
controls were analysed by mass spectrometry (MS) essentially as
described before [69]. To this end, protein spots were manually
excised, washed and destained using alternately 50% acetonitrile
(ACN) and 100 mM ammonium bicarbonate 3 times for 5 min.
After dehydrating with ACN and drying, protein spots were
digested overnight at 37uC with 10 mg/ml trypsin. Peptide samples
were extracted with ACN and trifluoroacetic acid and were then
co-crystallized with matrix (a-cyano-4-hydroxycinnamic acid) on a
stainless steel target using 1 ml matrix and 1 ml sample. Peptide
mass maps were generated on an Applied Biosystems Voyager-DE
STR time-of-flight mass spectrometer that was operated in
delayed reflector mode with an accelerated voltage of 20 kV.
Mass spectra were obtained by averaging 50 individual laser shots.
Samples were externally calibrated with a peptide mix of des-Arg-
bradykinin ([M+H]
+ 904.46), angiotensin I ([M+H]
+ 1296.68),
Glu1-fibrinopeptide B ([M+H]
+ 1570.67), ACTH (1-17) ([M+H]
+
2093.08), ACTH (18-39) ([M+H]
+ 2465.19) and the resulting mass
spectra were internally calibrated with trypsin autolysis products
(m/z 842.50 and m/z 2211.10). Monoisotopic peptide masses were
used for searches against the MSDB or NCBI nr database using
the Mascot peptide mass fingerprint software (Matrix Science,
Oxford, UK; http://www.matrixscience.com/search_form_select.
html) [70]. Carboxamidomethylation and methionine oxidation
were considered as variable modifications. Each hit was inspected
visually in order to fulfil the following quality control criteria:
optimized mass accuracy (approx. 50 ppm), minimal mass
deviation (in the mDa range), maximized sequence coverage,
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ion signals assigned to the identified protein.
Mass finger print analyses were confirmed by peptide sequence
analysis as described before [69]. Data acquisition was performed
using MassLynx (v 4.0) software while data were further processed
on Protein-Lynx-Global-Server (v 2.1), (Micromass, Manchester,
UK). Raw data files were deconvoluted and deisotoped using Max
Ent lite algorithm. Processed data were searched against MSDB
and Swisspro databases through Mascot search engine using a
peptide mass tolerance of 50 ppm and fragment tolerance of 100
mmu.
SDS-PAGE and immunoblotting
Infected and non-infected macrophages were lysed for 60 min
at 4uC in 1% Triton X-100, 150 mM NaCl, 50 mM Tris/HCl
pH 8.0, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM
PMSF, 1 mM EDTA, 1 mM Na3VO4 and 5 mg/ml each of
leupeptin, aprotinin and pepstatin. Soluble proteins from complete
cellular extracts, from cytosolic and nuclear fractions or after
oligonucleotide pull down (see above) were separated by standard
SDS-PAGE and were transferred to nitrocellulose by semidry
blotting. Non-specific binding sites were blocked using 5% dry
skimmed milk, 0.2% Tween-20, 0.02% NaN3 in PBS, pH 7.4.
Membranes were incubated overnight at 4uC with rabbit anti-
STAT1a (M-23; Santa Cruz Biotechnology), mouse monoclonal
anti-b-actin (clone AC15; Sigma-Aldrich, Taufkirchen, Germany)
or rabbit anti-BRG-1 (H-88; Santa Cruz Biotechnology) diluted in
5% dry skimmed milk, 0.05% Tween-20 in PBS, pH 7.4.
Fractionation into nuclear and cytosolic extracts was controlled
by incubating membranes with rabbit anti-BRG-1 and rabbit anti-
GAPDH (Sigma-Aldrich). Immune complexes were labelled with
horseradish-peroxidase-conjugated secondary antibodies (Dia-
nova, Hamburg, Germany) and visualized by ECL chemilumi-
nescence (GE Healthcare, Freiburg, Germany).
Immunofluorescence staining and confocal microscopy
Parasite development in host cells treated or not with HDAC
inhibitors was controlled by immunofluorescence microscopy.
Briefly, cells were fixed with 4% paraformaldehyde in 0.1
cacodylate buffer, pH 7.4 for 1 hour and quenched for 10 min
in 50 mM NH4Cl in PBS. After having been permeabilized for
1 hour using 0.1 mg/ml saponin and 1% BSA in PBS, cells were
incubated for 1 hour each with rabbit anti-Toxoplasma hyperim-
mune serum and Cy2-conjugated F(ab’)2 fragment donkey anti-
rabbit IgG (Dianova). The total cell population was stained with
5 mg/ml propidium iodide in PBS. Cells were examined by
confocal laser scanning microscopy using Leica TCS SP2.
FACS analysis
Expression of the MHC class II molecules H2-A/E in
macrophages treated or not with HDAC inhibitors was quantified
by FACS analysis as described previously [19]. Briefly, RAW264.7
macrophages infected or not with T. gondii for 40 hours (parasite-
host cell ratio of 1:1 (RH-LDM) or 3:1 (NTE, PTG), and treated
or not with HDAC inhibitors 2 hour prior to IFN-c treatment,
were collected by scraping and washed twice. Cells (5610
5 per
staining) were incubated in FACS buffer (1% BSA, 0.1% NaN3 in
PBS) supplemented with 1 mg/ml normal mouse IgG. They were
then consecutively immunolabelled with 2 mg/ml of rat mAb anti-
H2-A/E (clone M5/114.15.2. ATCC, Rockville, MD, USA) or
isotype control antibody (R35-38, BD Biosciences, Heidelberg,
Germany) and R-PE-conjugated donkey F(ab’)2 fragment anti-rat
IgG secondary antibody. After having been washed and fixed in
1% paraformaldehyde, 10.000 cells per sample were analyzed on a
FACSCalibur flow cytometer (BD Biosciences).
Chromatin immunoprecipitation (ChIP)
Acetylation of histones and recruitment of BRG-1 to chromatin
was analysed using the ChIP assay kit (Upstate Cell Signaling
Solutions, Lake Placid, NY, USA). To this end, T. gondii-infected
and non-infected control RAW264.7 macrophages stimulated or
not with 300 U/ml IFN-c were fixed in 1% formaldehyde at 37uC
for 10 min. After having been washed twice with ice-cold PBS
supplemented with 1 mM PMSF and 1 mg/ml each of aprotinin
and pepstatin, cells were collected by scraping. Cells (0.75610
7 per
sample) were then lysed in 0.75 ml of SDS lysis buffer (Upstate)
containing 1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1,
and protease inhibitors (as above) for 10 min on ice. Chromatin
was sheared on ice by sonification (Branson Sonifier 250; Branson
Ultrasonics, Danbury, CT) with twenty 10 sec-pulses to obtain
DNA fragments of 200–800 bp. After centrifugation at 18.0006g
and 4uC for 10 min, 200 ml supernatant were diluted 10-fold in
ChIP Dilution buffer (Upstate) containing 0.01% SDS, 1.1%
Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl (pH 8.1),
167 mM NaCl and protease inhibitors. In order to quantify the
amount of input DNA, 20 ml of diluted DNA from each sample
were removed and further processed as described below. The
remaining diluted DNA was pre-cleared for 30 min at 4uC with
75 ml of salmon sperm DNA/protein A agarose (Upstate). After
centrifugation, the supernatants were incubated overnight at 4uC
with 5 ml of ChIP grade rabbit polyclonal anti-acetyl-H4 or anti-
acetyl-H3 (both from Upstate), or with 3 mg of ChIP grade anti-
BRG-1 (Santa Cruz Biotechnology). A negative control precipi-
tation without antibody was run in parallel. Immune complexes
were collected using 60 ml of salmon sperm DNA/protein A
agarose for 60 min at 4uC and subsequent centrifugation. Samples
were then washed consecutively in low salt wash buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl
(pH 8.1), 150 mM NaCl), high salt wash buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM
NaCl), LiCl wash buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1%
sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1)),
and twice in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).
After the final centrifugation, pellets were incubated twice for
15 min at room temperature in 1% SDS, 0.1 M NaHCO3. DNA-
protein cross-links of the eluted histone-DNA complexes and of the
input DNA (see above) were reversed by treatment for 4 hours at
65uC with 200 mM NaCl, and proteins were digested with 40 mg/
ml proteinase K in 10 mM EDTA, 40 mM Tris-HCl, pH 6.5 for
60 min at 45uC. DNA was finally isolated using the PCR
purification kit (Qiagen) and was quantified by real-time PCR.
In some experiments, the ChIP-IT Express Enzymatic Kit (Active
Motif, Carlsbad, CA) was used as recommended by the
manufacturer.
Quantitative real-time PCR
Quantitative real-time PCR of mouse transcripts was used to
validate microarray results. Transcripts were selected to represent
diverse expression patterns after stimulation of non-infected
macrophages with IFN-c as judged by cDNA microarray. Total
RNA from BMMW stimulated or not with IFN-c and/or infected
with T. gondii as described above was isolated using the RNeasy kit
(Qiagen). Following reverse transcription of mRNA using the
Omniscript kit (Qiagen), serial dilutions of cDNA were amplified by
PCR in a LightCycler with the SYBR Green FastStart DNA
Master
Plus Set (Roche, Mannheim, Germany) using mouse-specific
primer pairs as specified in Table S4. Data were analyzed as
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were calculated as the fold change between unstimulated (control)
and either IFN-c-stimulated, non-infected BMMW or IFN-c-treated
and T. gondii-infected BMMW (samples) using the formula Ratio
=( E target)
DCPtarget(control-sample)/(Eref)
DCPref(control-sample),w h e r et h e
referencegenewasb-actin and the target genes were IFN-c-regulated
genes.
Real-time PCR was also used to quantify DNA isolated by ChIP.
To this end, input DNA or ChIP DNA was amplified using primers
specific for the CIITA promoter IV (for: 59-TGCCTTTG-
GCCCAAAGCTGAA-39; rev: 59-TTCTGAGTGCTGCCTGC-
ATGC-39), H2-Eb (for: 59-AAACAACCCAAAGCAAAACC-39;
rev: 59-TCAGCATCAAAGGAGTCCAG-39), GBP2 (for: 59-G-
CTGGCAACTTCACAAAACA-39; rev: 59-TGCCAGAGAAC-
TTGTGAG-GA-39)o rb-actin (for: 59-GATGACCCAGAT-
CATGTTTGAGAC-39; rev: 59-TGCTCG-AAGTCTAGAGCA-
ACATAG-39). The IFN-c-induced acetylation of histones or
BRG-1 recruitment was calculated according to Ratio =
(EChIP)
DCPChIP(unstimulated – IFN-c-treated)/(Einput)
DCPinput(unstimulated – IFN-c-treated),
where input and ChIP refer to samples before and after
immunoprecipitation, respectively.
Semi-quantitative RT-PCR
Total RNA was isolated from infected and non-infected
RAW264.7 monocytes/macrophages that had been treated with
IFN-c in the absence or presence of HDAC inhibitors. After
reverse transcription, H2-Ab and CIITA cDNAs were amplified as
described previously [19]. Amplification of b-actin was used as an
internal standard in order to normalize the amount of cDNA
present in each sample. PCR products were separated by agarose
gel electrophoresis and semi-quantitatively analysed using a
BioDoc II digital imaging system (Biometra, Go ¨ttingen, Germany).
Statistical analysis
Results are expressed as means 6 S.E.M. of three independent
experiments unless otherwise stated. Significant differences
between mean values were identified by the Student’s t-test. P-
values of less than 0.05 were considered significant.
Accession numbers
beta-actin (syn. actin, cytoplasmic 1), NM_007393
BRG-1, NM_001174078
CD14, NM_009841
CD69, NM_001033122
CFB (complement factor B), NM_001142706
CIITA (class II transactivator), NM_007575
CXCL11, NM_019494
Fc-gamma receptor 1, NM_010186
FLT1 (FMS-like tyrosine kinase 1), NM_010228
Fyn kinase, NM_008054
GAPDH, NM_008084
gamma-actin (syn. actin, cytoplasmic 2), NM_009609
GBP2 (guanylate binding protein), NM_010260
G-protein linked C3G, NM_054050
H2-Aa, NM_010378
H2-Ab, NM_207105
H2-DMb1, NM_010387
H2-Ea, NM_010381
H2-Eb, NM_010382
histone H3, NM_145073
histone H4, NM_175652
IFIT2 (interferon-induced protein with tetratricopeptide repeats
2), NM_008332
IL-10, NM_010548
iNOS, NM_010927
interferon-gamma (IFN-g), NM_008337
IFN-gamma receptor (IFN-gR1), NM_010511
IGTP (interferon-gamma-induced GTPase), NM_018738
IRF-1 (interferon-regulatory factor 1), NM_008390
IP-10 (syn. CXCL10), NM_021274
MIG (syn. CXCL9), NM_008599
MMP9, NM_013599
MX1 (myxovirus (influenza virus) resistance 1), NM_010846
myosin 1, NM_001080775
p48 (syn. IRF9, ISGF3c), NM_001159417
PI3K (catalytic alpha chain), NM_008839
Rap-1, NM_145541
SHP-1 (syn. PTPN6), NM_013545
SHP-2 (syn. PTPN11), NM_011202
STAT1 (signal transducer and activator of transcription 1),
NM_009283
STAT2 (signal transducer and activator of transcription 2),
NM_019963
TNF-alpha, NM_013693
tropomyosin 3, NM_022314
Supporting Information
Figure S1 Validation of microarray data by quantitative RT-
PCR. (A) Transcripts that were regulated or not by IFN-c in
primary BMMW were randomly selected from the microarray.
The change of mRNA abundance following T. gondii infection (x-
fold) as measured by microarray was compared with the respective
real-time PCR data. (B) Microarray data on the IFN-c-regulated
mRNA change as observed after Toxoplasma infection were plotted
against the corresponding data retrieved from real-time PCR. The
correlation coefficient r was obtained after a linear regression
analysis.
(TIF)
Figure S2 HDAC inhibitor MS-275 restores defective H2-A/E
expression in parasite-positive and parasite-negative macrophages
following infection with T. gondii. RAW264.7 macrophages were
infected with GFP-expressing type II PTG and type I RH parasites
at parasite-host cell ratios of 3:1 or 1:1, respectively, or were left
non-infected. Cells were treated with 2 mM MS-275, or were mock
treated as indicated, and two hours later, were stimulated or not
with IFN-c. Forty hours after infection, cells were immunolabelled
with anti-H2-A/E, and were analysed by flow cytometry. Results
are from a representative experiment out of two. Percentages of
cells within the individual quadrants or within the two upper and
lower quadrants are indicated.
(TIF)
Figure S3 Replication of T. gondii in the presence of HDAC
inhibitors. (A) RAW264.7 macrophages were infected with T.
gondii at a parasite-host cell ratio of 3:1 and were treated at 1 hour
post infection with MS-275, sodium butyrate, MC1568 (all at
2 mM), or nicotinamide (5 mM), or were mock treated. Fourty
hours after infection, cells were fixed and labelled with polyclonal
anti-T. gondii serum and propidium iodide. Representative images
obtained by confocal fluorescence microscopy are shown. (B) After
treatment of T. gondii with HDAC inhibitors as described in (A),
the average number of parasites per parasitophorous vacuole was
calculated. Results are means 6 S.E.M. from two experiments.
(TIF)
Figure S4 Defective IFN-c-induced H2-A/E expression after
infection of murine macrophages with T. gondii is restored by
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RAW264.7 macrophages were infected with T. gondii (parasite-
host cell ratio 3:1, lower panel) or were left non-infected (upper
panel), and were stimulated or not with IFN-c as indicated. Two
hours prior to cytokine stimulation, cells were treated with MS-
275, nicotinamide, or MC1568, or were mock treated. Forty hours
after infection, cells were immunolabelled with anti-H2-A/E, and
were analysed by flow cytometry. Results are from a representative
experiment out of three, data are the percentages of cells within
the individual quadrants. (B) Murine macrophages were infected
with T. gondii and/or treated with IFN-c and HDAC inhibitors as
described in (A). Cells were immunolabelled with anti-mouse H2-
A/E or an isotype-matched control antibody, and were analysed
by flow cytometry. Data represent the mean percentages 6 S.E.M.
of positive cells from three independent experiments. *: p,0.05,
ns: not significant (Student’s t-test).
(TIF)
Table S1 Expression of IFN-c-inducible genes in T. gondii-
infected and non-infected BMMW. Differentially expressed genes
after treatment of non-infected BMMW with IFN-c (IFN-c, n.i. vs
untreated, n.i.) were identified by ANOVA; those at least four-fold
up-regulated (absolute value) at a false-discovery rate # 1% were
included in the list. Expression in non-infected BMMW was
compared with that in Toxoplasma-infected BMMW (IFN-c, T.
gondii vs untreated, T. gondii) and the parasite effect was calculated
[x-fold].
(XLSX)
Table S2 Expression of IFN-c-repressed genes in T. gondii-
infected and non-infected BMMW. Differentially expressed genes
after treatment of non-infected BMMW with IFN-c (IFN-c, n.i. vs
untreated, n.i.) were identified by ANOVA; those at least four-fold
down-regulated (absolute value) at a false-discovery rate # 1%
were included in the list. Expression in non-infected BMMW was
compared with that in Toxoplasma-infected BMMW (IFN-c, T.
gondii vs untreated, T. gondii) and the parasite effect was calculated
[x-fold].
(XLSX)
Table S3 IFN-c-regulated biological processes which are
predominantly counteracted by T. gondii. Genes that were
differentially expressed after treatment of non-infected BMM with
IFN-c (at least four-fold; identified by ANOVA), but not in those
previously infected with T. gondii were subjected to the functional
annotation of biological processes using the DAVID Bioinfor-
matics resource. Major functional targets of parasite interference
were identified by including those GO annotation terms that were
common to at least five genes, and that were significantly enriched
(modified Fisher’s exact test, P,0.1). The level of enrichment of
genes was determined against all Mus musculus genes.
(XLSX)
Table S4 Primers used for validation of microarray results by
quantitative real-time PCR.
(DOC)
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